mGluR5 has been implicated in multiple brain disorders, including schizophrenia [17], Alzheimer’s disease [18,19], Parkinson’s disease [20], major depressive disorder (review [21]) and fragile X syndrome [22,23,24]. This evidence concerns the gene GRM5 and early-onset autosomal dominant Alzheimer disease.